Highlights
NASDAQ: AKCA       Akcea Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
19.92   -0.72 (3.49%)  19.92 - 20.60  31,529

Overview

 
Avg Volume (4 weeks):177,125
4 Weeks Range:17.70 - 21.00
4 Weeks Price Volatility (%):
67.27%
52 Weeks Range:13.90 - 35.82
52 Weeks Price Volatility (%):
27.46%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

  Be the first to like this.
 


 

1486  3908  671  2912 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AABA 19.630.00 
 ACB 2.955+0.315 
 AMD 39.875-1.105 
 HEPA 3.975+1.555 
 M 14.59-0.43 
 UBER 29.339+1.309 
 SCHW 48.49+3.74 
 CHK 0.576+0.005 
 AMTD 49.30+7.92 
Partners & Brokers